EUVIMEDEUVIMED entdecken
Crossref

Synthesis and Carbonic Anhydrase I, II, IX, and XII Inhibition Studies with a Series of Cyclic Sulfonyl Guanidines

Morteza Abdoli iD, Alessandro Bonardi iD, Claudiu T Supuran iD, Raivis Žalubovskis iD

ChemMedChem · 2024

DOI: 10.1002/cmdc.202400197 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Morteza Abdoli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemistry and Chemical Technology, Faculty of Natural Sciences and Technology, Riga Technical University, P. Valdena iela 3, LV-1048, Ri…. Hauptthemen laut MEDLINE: Carbonic Anhydrase Inhibitors, Carbonic Anhydrases, Guanidines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: European Regional Development Fund [ERDF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of thirteen cyclic sulfonyl guanidines were prepared and evaluated against tumor‐associated human (h) carbonic anhydrase (CA, EC 4.2.1.1) isoforms hCA IX and hCA XII, as well as against off‐target cytosolic isoforms hCA I and hCA II. The compounds reported here were generally inactive against both off‐target isoforms ( K I >100 μM), while all of them moderately inhibited both target isoforms hCA IX and XII in the submicromolar to micromolar ranges in which K I values spanned from 0.57 to 8.4 μM against hCA IX and from 0.34 to 9.7 against hCA XII. Due to the notable selectivity of the title compounds toward isoforms hCA IX and XII, they can be considered as useful scaffolds for further chemical optimization to develop new highly selective antitumor agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbonic Anhydrase InhibitorsCarbonic AnhydrasesGuanidinesHumansStructure-Activity RelationshipMolecular StructureCarbonic Anhydrase IICarbonic Anhydrase IXCarbonic Anhydrase IDose-Response Relationship, DrugIsoenzymesAntigens, Neoplasm

Stichwörter der Autor:innen

Antitumor agentsCancer-related isoformsCarbonic anhydrase inhibitorsSulfaguanidinesSulfonamides

Substanzen

Carbonic Anhydrase InhibitorsCarbonic AnhydrasesGuanidinescarbonic anhydrase XIICarbonic Anhydrase IICarbonic Anhydrase IXCarbonic Anhydrase IIsoenzymesCA9 protein, humanAntigens, Neoplasm

Autor:innen und Institutionen

  • Institute of Chemistry and Chemical Technology, Faculty of Natural Sciences and Technology, Riga Technical University, P. Valdena iela 3, LV-1048, Riga, Latvia.
  • NEUROFARBA Department, Pharmaceutical and Nutraceutical Section, University of Florence, Via Ugo Schiff 6, 50019, Florence, Italy.
  • Latvian Institute of Organic Synthesis, Aizkraukles 21, LV-1006, Riga, Latvia.

ORCID-Profile: Morteza Abdoli, Alessandro Bonardi, Claudiu T Supuran, Raivis Žalubovskis

Förderung

  • European Regional Development Fund [ERDF

Zitieren

APA

Abdoli, M., Bonardi, A., Supuran, C. T., & Žalubovskis, R. (2024). Synthesis and Carbonic Anhydrase I, II, IX, and XII Inhibition Studies with a Series of Cyclic Sulfonyl Guanidines. ChemMedChem. https://doi.org/10.1002/cmdc.202400197

Vancouver

Abdoli M, Bonardi A, Supuran CT, Žalubovskis R. Synthesis and Carbonic Anhydrase I, II, IX, and XII Inhibition Studies with a Series of Cyclic Sulfonyl Guanidines. ChemMedChem. 2024. doi:10.1002/cmdc.202400197

BibTeX
@article{Abdoli2024,
  author = {Abdoli, Morteza and Bonardi, Alessandro and Supuran, Claudiu T and Žalubovskis, Raivis},
  title = {Synthesis and Carbonic Anhydrase I, II, IX, and XII Inhibition Studies with a Series of Cyclic Sulfonyl Guanidines},
  journal = {ChemMedChem},
  year = {2024},
  doi = {10.1002/cmdc.202400197}
}
Kostenlos starten →